Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens

PJ Voogt, WE Fibbe, WAF Marijt, WFJ Veenhof… - The Lancet, 1990 - Elsevier
PJ Voogt, WE Fibbe, WAF Marijt, WFJ Veenhof, M Hamilton, FE Zwaan, R Willemze
The Lancet, 1990Elsevier
A female patient showed rejection of a T-lymphocyte-depleted bone-marrow graft from her
phenotypically HLA-identical father. Before bone-marrow transplantation, there was strong
recipient anti-donor cellular cytotoxic reactivity directed against several minor
histocompatibility (mH) antigens, including the male-specific HY antigen. After conditioning
treatment, no recipient anti-donor cytotoxic activity could be detected, and good graft
function was shown a month after transplantation. Thereafter, however, graft function …
Abstract
A female patient showed rejection of a T-lymphocyte-depleted bone-marrow graft from her phenotypically HLA-identical father. Before bone-marrow transplantation, there was strong recipient anti-donor cellular cytotoxic reactivity directed against several minor histocompatibility (mH) antigens, including the male-specific H-Y antigen. After conditioning treatment, no recipient anti-donor cytotoxic activity could be detected, and good graft function was shown a month after transplantation. Thereafter, however, graft function deteriorated rapidly, while recipient-derived anti-donor cellular cytotoxic reactivity, against similar mH antigens, reappeared. The recipient-derived cytotoxic T lymphocytes could completely inhibit growth of donor haemopoietic progenitor cells both before and after bone-marrow transplantation. Thus, cytotoxic T lymphocytes can survive very intensive conditioning regimens, and residual recipient cytotoxic T lymphocytes directed against mH antigens expressed on donor haemopoietic progenitor cells may cause graft rejection after HLA-identical T-lymphocyte-depleted bone-marrow transplantation.
Elsevier